Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1431 | ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 25.62 USD | -2.21% | +1.59% | +17.20% | +21.88% | 4.39 B USD | ||
| 1450 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 35.02 USD | -5.33% | +0.78% | +11.32% | -3.45% | 4.09 B USD | ||
| 1458 | DNLI Denali Therapeutics Inc. - Common Stock | 25.71 USD | -2.28% | -0.62% | +29.59% | +59.00% | 4.08 B USD | ||
| 1518 | GPCR Structure Therapeutics Inc - American Depositary Shares | 53.30 USD | -5.88% | +3.19% | +33.25% | +99.33% | 3.79 B USD | ||
| 1530 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.36 USD | -3.24% | -4.38% | +20.34% | +80.03% | 3.85 B USD | ||
| 1532 | CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.48 USD | -0.03% | +0.13% | +0.58% | +48.42% | 3.85 B USD | ||
| 1537 | ALMS Alumis Inc. - Common Stock | 29.17 USD | -0.34% | +6.00% | +50.98% | +546.78% | 3.60 B USD | ||
| 1555 | BEAM Beam Therapeutics Inc. - Common Stock | 36.36 USD | -4.11% | +5.67% | +18.09% | +67.10% | 3.74 B USD | ||
| 1567 | RCUS Arcus Biosciences, Inc. Common Stock | 29.31 USD | -3.24% | -1.08% | +24.25% | +240.42% | 3.69 B USD | ||
| 1590 | RLAY Relay Therapeutics, Inc. - Common Stock | 18.50 USD | -6.28% | +1.48% | +32.24% | +418.21% | 3.54 B USD | ||
| 1595 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 39.79 USD | -1.78% | +9.31% | +31.23% | +22.13% | 3.50 B USD | ||
| 1606 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.62 USD | -0.18% | +5.18% | +26.12% | +97.43% | 3.45 B USD | ||
| 1621 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 34.33 USD | -4.29% | +4.54% | +55.06% | -14.11% | 3.38 B USD | ||
| 1626 | DYN Dyne Therapeutics, Inc. - Common Stock | 22.48 USD | -5.67% | +2.88% | +31.00% | -3.97% | 3.21 B USD | ||
| 1644 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 19.85 USD | -4.66% | -10.42% | +17.25% | +15.01% | 3.18 B USD | ||
| 1675 | CLDX Celldex Therapeutics, Inc. - Common Stock | 39.13 USD | -2.00% | +6.13% | +34.79% | +43.65% | 3.07 B USD | ||
| 1684 | ELVN Enliven Therapeutics, Inc. - Common Stock | 48.75 USD | -4.26% | -0.20% | +41.72% | +135.96% | 2.97 B USD | ||
| 1688 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 41.06 USD | -4.42% | -3.95% | +26.57% | +38.06% | 2.95 B USD | ||
| 1701 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 68.45 USD | -2.98% | +9.33% | +13.59% | +3.62% | 2.94 B USD | ||
| 1715 | IRON Disc Medicine, Inc. - Common Stock | 77.58 USD | -2.73% | +5.88% | +15.69% | +45.34% | 2.96 B USD |
Notícias Biotechnology Stocks
BofA mantém recomendação de compra para Beam Therapeutics após decisão arbitral
Dinamarca - Ações fecharam o pregão em queda e o Índice OMX Copenhagen 20 recuou 1,33%
‘Por que a CVM não viu isso antes?’
Por que as ações da Beam Therapeutics estão caindo hoje?
Por que as ações da Prime Medicine estão disparando hoje?
Ação da Incyte atinge máxima de 52 semanas em US$ 118,77
Ações da Prime Medicine disparam após vitória em arbitragem contra a Beam
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |